Mass-Fix has been recognized by the International Myeloma Working Group as an alternative to immunofixation, and is now recommended for diagnosing and monitoring patients with monoclonal protein disorders.
BioChromato Rapid EPS seals prevent contamination issues and autosampler needle clogging when accessing samples stored in 96-well microplates ready for LC/MS analysis.
Finding themselves in a vicious tug-of-war, clinical labs are struggling to keep pace with emerging designer drugs.
NanoPin’s diagnostic platform using Thermo Fisher’s advanced LC-MS technology will create sensitive clinical assays for infectious disease.
Multiple highly specific binders have been generated that bind to the spike proteins of SARS-CoV-2 and do not crossreact with other closely related viruses.
Clinical laboratories continue to play a vital role when it comes to diabetes diagnosis.